Google's new CFO Anat Ashkenazi raked in a nearly $10 million signing bonus

Tech Insider
Google campus located in California
Google's parent company, Alphabet, on Wednesday announced the appointment of its new CFO, former Eli Lilly executive Anat Ashkenazi.

Melina Mara/The Washington Post via Getty Images

Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs says

Tech Insider
Zepbound
Zepbound is Eli Lilly's new weight-loss drug.

Brendan McDermid/Reuters

A Gen Z diabetic said a 3-month supply of insulin pumps would cost her $1,800 — even with insurance

Tech Insider : Economy, Economy
Grace stands in her scrubs with a stethoscope around her shoulders.
Grace Cochran, 25, is a nurse in Charlotte, North Carolina. On her TikTok account, she share her experience navigating the healthcare system as a Type 1 diabetic.

Grace Cochran

Healthcare companies are promising to help patients quit Wegovy. There's just one problem with that.

Tech Insider
Illustration of person and Ozempic pen.

Cornelia Li for Business Insider

Ozempic maker plans manufacturing blitz as market for the drug is expected to top $100 billion in 2030

Tech Insider
woman holding ozempic pen

Getty Images

A new ETF will allow investors to cash in on the Ozempic-fueled weight loss craze that's swept markets this year

Tech Insider
Ozempic box
Ozempic.

Getty Images

Weight-loss drugs just got cheaper — and better

Tech Insider
a close up of a person measuring their waist size
More research suggests the medication tirzepatide leads to significant weight loss.

Mario Castello/Corbis/VCG

Ozempic and other weight-loss drugs will power the anti-obesity market to 16-fold gains by 2030, Goldman Sachs says

Tech Insider
Ozempic box
Weight-loss drugs could fuel huge gains for the anti-obesity market, according to Goldman Sachs.

Getty Images

Subscribe to eli-lilly